Search
Eribulin
go.drugbank.com/drugs/DB08871ApprovedInvestigationalEribulin is also being investigated for use in the treatment of advanced solid tumors [A7439]. … Eribulin is a microtubule inhibitor indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic
Products: ERIBULINA EG, HALAVEN 0.5 mg/ml solution for injectionMaraviroc
go.drugbank.com/drugs/DB04835ApprovedInvestigationalIt was originally labelled as UK-427857 during development but was assigned the Maraviroc name as it entered trials. It was approved for use by the FDA in August, 2007.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesProducts: CELSENTRI® 150 MG, CELSENTRI 150 MG FILM KAPLI TABLET ,180 ADETSulbactam
go.drugbank.com/drugs/DB09324ApprovedInvestigational[L50131] When given in combination with β-lactam antibiotics, sulbactam produces a synergistic effect as it blocks the enzyme responsible for drug resistance by hydrolyzing β-lactams.[A263296]
Mixtures: CEFTRIAXONA 1000 MG + SULBACTAM 500 MG, BACTAMED 500 MG/250 MG IM IV ENJEKTABL TOZ IÇEREN FLAKON, 10 ADETCategories: Heterocyclic Compounds, 2-RingSelenious acid
go.drugbank.com/drugs/DB11127ApprovedIt also plays an important role in maintaining the general health of tissue and muscle and has antioxidant properties. … Selenium is an essential trace element and antioxidant. It is a cofactor metabolic enzyme regulation.
Mixtures: TRACUTIL® 10 ML AMPOLLAS, ADDAMEL N 20 AMPULProducts: Selenase 100 Mikrogramm/2 ml - Lösung zum Einnehmen, Selenase 500 Mikrogramm/10 ml - Lösung zum EinnehmenCanagliflozin
go.drugbank.com/drugs/DB08907ApprovedInvestigationalIt was initially approved by the FDA in 2013 for the management of diabetes and later approved in 2018 for a second indication of reducing the risk of cardiovascular events in patients diagnosed with type … Canagliflozin, also known as _Invokana_, is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used in the management of type 2 diabetes mellitus along with lifestyle changes including diet and exercise
Mixtures: FILM-COATED TABLETS 50 MG / 1000 MG, VOKANAMET 50 MG/1000 MG FİLM KAPLI TABLET, 60 ADETCategories: Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors, Drugs Used in DiabetesEssential Thrombocythemia (ET)
go.drugbank.com/conditions/DBCOND0048758Synonyms: ET (Essential Thrombocythemia), Essential Thrombocythemia (ET)Calcium
go.drugbank.com/drugs/DB01373ApprovedInvestigationalNutraceuticalBone serves as an important storage point for calcium, as it contains 99% of the total body calcium. Low calcium intake may also be a risk factor in the development of osteoporosis. … Circulating calcium is either in the free, ionized form or bound to blood proteins such as serum albumin. Although calcium flow to and from the bone is neutral, about 5 mmol is turned over a day.
Mixtures: BONMEGA 70 MG/2800 IU+1000 MG TEDAVI PAKETI, 4+24 ADET, FIXOSS 70 MG/5600 IU+1000 MG TEDAVI PAKETI 4+24 EFERVESAN TABLETProducts: Tropicana Calcium Supplement 344 mg, Tropicana Calcium Supplement 393 mgMoclobemide
go.drugbank.com/drugs/DB01171ApprovedInvestigationalMost meta-analyses and most studies indicate that in the acute management of depression, moclobemide is more efficacious than placebo medication and similarly efficacious as tricyclic antidepressants (
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C9 SubstratesSynonyms: 4-Chlor-N-(2-morpholinoethyl)benzamid, p-Chloro-N-(2-morpholinoethyl)benzamideDorzolamide
go.drugbank.com/drugs/DB00869ApprovedInvestigational[L11377] It works by blocking an enzyme in the ciliary process that regulates ion balance and fluid pressure in the eyes. … [A1304] First marketed in 1995,[A190624] dorzolamide is available in ophthalmic solutions as monotherapy marketed as Trusopt [L11377] or in combination with [timolol] as Cosopt PF.[L11380]
Mixtures: DORZOLAMIDE E TIMOLOLO EG, DORZOLAMIDE E TIMOLOLO EGCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C9 SubstratesTenofovir alafenamide
go.drugbank.com/drugs/DB09299ApprovedInvestigational[A178219] It has been reported to produce a large antiviral efficacy at doses ten times lower than tenofovir disoproxil. … [L4388,L9010] Tenofovir alafenamide was developed by Gilead Sciences Inc and granted FDA approval on 5 November 2015.[L6271]
Mixtures: BİKTARVY 50 MG / 200 MG / 25 MG FİLM KAPLI TABLET, 30 TABLET, BİKTARVY 50 MG / 200 MG / 25 MG FİLM KAPLI TABLET, 90 TABLETCategories: Heterocyclic Compounds, 2-Ring, Antivirals used in combination for the treatment of HIV infections